News

The USFDA has approved the first-ever blood test to help diagnose Alzheimer's disease, offering a faster, less invasive, and ...
Experts say the test could dramatically improve access to earlier, more accurate diagnoses, particularly for older Americans ...
Since Alzheimer's disease affects over 7 million people in the U.S., potentially doubling to 14 million by 2050, earlier ...
The Global Alzheimer’s Platform Foundation® (GAP) applauds the FDA's clearance of the first blood test to diagnose ...
The Lumipulse blood test identifies the presence of amyloid plaques, a hallmark of Alzheimer’s disease that impairs normal brain function.
Fujirebio today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s ...